A Study of How the Body Breaks Down and Eliminates LY2623091

NCT02242981 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: LY2623091

Sponsor

Eli Lilly and Company